Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biomerica Inc

Current price
0.74 USD -0.048 USD (-6.07%)
Last closed 0.77 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 13 928 285 USD
Yield for 12 month -57.32 %
21.11.2021 - 28.11.2021

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. Address: 17571 Von Karman Avenue, Irvine, CA, United States, 92614

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

13 USD

P/E ratio

Dividend Yield

Current Year

+5 339 000 USD

Last Year

+18 871 409 USD

Current Quarter

+1 017 000 USD

Last Quarter

+1 567 000 USD

Current Year

+446 000 USD

Last Year

+2 977 418 USD

Current Quarter

+1 017 000 USD

Last Quarter

+325 000 USD

Key Figures BMRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 307 780 USD
Operating Margin TTM -196.66 %
PE Ratio
Return On Assets TTM -43.02 %
PEG Ratio
Return On Equity TTM -92.06 %
Wall Street Target Price 13 USD
Revenue TTM 5 407 558 USD
Book Value 0.46 USD
Revenue Per Share TTM 0.32 USD
Dividend Share
Quarterly Revenue Growth YOY -8.5 %
Dividend Yield
Gross Profit TTM 446 000 USD
Earnings Share -0.38 USD
Diluted Eps TTM -0.38 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -117.41 %

Dividend Analytics BMRA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BMRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:2
Payout Ratio
Last Split Date 14.11.1994
Dividend Date

Stock Valuation BMRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.4054
Price Sales TTM 2.5757
Enterprise Value EBITDA -1.2942
Price Book MRQ 1.4844

Financials BMRA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BMRA

For 52 weeks

0.7 USD 2.13 USD
50 Day MA 0.99 USD
Shares Short Prior Month 76 728
200 Day MA 1.06 USD
Short Ratio 1.55
Shares Short 66 496
Short Percent 0.43 %

Dynamics of changes in the value of assets




414.58 USD Microsoft Corporation +0.12 (+0.03%)
Detailed analytics

ETF funds



208.70 CHF iShares MDAX UCITS ETF (DE) -11.84 (-4.92%)
Detailed analytics



2169.94 USD Gold -5.94 (-0.27%)
Detailed analytics